Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding.
about
Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminusHuman bocavirus capsid structure: insights into the structural repertoire of the parvoviridaeCross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroupsAdeno-associated Virus as a Mammalian DNA VectorParvovirus glycan interactionsPolymers for improving the in vivo transduction efficiency of AAV2 vectorsStructure of Adeno-Associated Virus Serotype 8, a Gene Therapy VectorThe structure of adeno-associated virus serotype 3B (AAV-3B): Insights into receptor binding and immune evasionStructural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal TraffickingStructural Insights into Adeno-Associated Virus Serotype 5Electron microscopy analysis of a disaccharide analog complex reveals receptor interactions of adeno-associated virusStructure of AAV-DJ, a Retargeted Gene Therapy Vector: Cryo-Electron Microscopy at 4.5 Å ResolutionE Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV EvolutionStructure of neurotropic adeno-associated virus AAVrh.8.The structure of human parvovirus B19Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications.Comparative analysis of adeno-associated virus capsid stability and dynamicsOvercoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectorsSCHEMA computational design of virus capsid chimeras: calibrating how genome packaging, protection, and transduction correlate with calculated structural disruption.Directed evolution of adeno-associated virus yields enhanced gene delivery vectors.Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism.Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transferIn vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles.Molecular engineering of viral gene delivery vehiclesDNA shuffling of adeno-associated virus yields functionally diverse viral progenyHeart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library.Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy.Structure of adeno-associated virus type 4.An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cellsEngineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer.A NEW RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BASED RANDOM PEPTIDE DISPLAY LIBRARY SYSTEM: INFECTION-DEFECTIVE AAV1.9-3 AS A NOVEL DETARGETED PLATFORM FOR VECTOR EVOLUTION.Titer and product affect the distribution of gene expression after intraputaminal convection-enhanced delivery.Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle.Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells.Molecular characterization of adeno-associated viruses infecting childrenHost-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence.Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter.
P2860
Q24563214-B4C1FAC4-B52F-4478-BC5E-5580A56C3DA2Q24606666-BF42D8C7-30D1-4AFE-9F8E-110F988B5D56Q24623923-C8E66F81-5F63-4999-B7AE-C92DC5BF28A3Q26782605-0027BE49-45CF-425D-977A-3B83EB7F9B65Q26858992-D90050A6-9968-4C51-8F0B-957DFD41B58DQ27438107-349BCDC7-C777-4882-A0C8-E972BEE6660FQ27647639-D81FF9A2-3880-48B1-BECA-2224CD044D59Q27661320-7CD8993D-63AA-4392-A075-DFA433FAF89CQ27664641-8B9C282C-DA51-4A43-B79E-EA408F99BF55Q27673394-EDFF5BC0-89E0-4316-992E-D59D6A641B47Q27679454-912C45C6-F784-4BA2-82CD-1E975B660532Q27679952-70D969D8-09AD-47CC-AE99-9A42389C1B49Q27681347-AC27DA78-0529-496B-AF81-306E951ED504Q28083324-98BE689D-80EA-4B21-8EAD-15E61F6E2A44Q30152836-244C652C-3109-4610-9A70-D2FD04FC724EQ30163895-18BFAB8C-C28C-4126-86D9-7D80379FE6B6Q30427066-6AE1F676-E91C-4A43-8C03-2A1767220632Q30557598-1C4A800C-875A-4B86-ADF3-8B2B2682B975Q30650955-02F5FA3E-F1F3-4FCF-85FC-5C5D99309A78Q31125144-A55438B7-927E-4B50-9687-0D904E8A18A1Q33232270-C3184F0A-5747-42B0-863D-F7F93AA3D9C9Q33248410-E6B1A928-2E0E-4074-BDAC-3B17FB48AC86Q33296224-B94A5F2B-99A9-43F9-9813-C74A022F586AQ33327474-D0235C52-D973-4E81-B2F5-12B866148EC5Q33337378-97F0307F-35FA-4C3D-A071-C6672F3400BFQ33353795-1033F82F-9B95-45C5-AB69-1710A12F6A29Q33363531-5F7D21DF-3CF3-4388-A937-7834871C6C50Q33555864-2C39E9D5-5D36-440D-9B5F-8FC998FFDF8FQ33587005-CCD5A52F-09D4-463B-9D7C-EB555E16AC74Q33724158-EE6B8D1D-E9F4-4A2A-916D-103D41F2B4A4Q33790771-EB93F2F1-E0E7-4037-A88A-5C01E5AAB5F6Q33833473-98E6E1C7-7BDA-4B70-A814-B1093CB2F6E8Q33908400-2094D9C6-C503-4FBF-8CCC-753792A71849Q34024890-71B28FD0-44DB-4E58-B601-C04C87A8CB9AQ34028528-12FECEFC-2E85-49FC-8103-6168823A0C92Q34034500-E46A2BAA-F166-4815-B0EE-C72B87D442EDQ34080512-562453C5-1BFE-4B30-91D0-E0FBC8DAD83EQ34142840-EE24C5D4-CDDA-4AE7-90E2-792BB6BFE722Q34302122-CF6D1945-D209-461F-8E6B-B299A7152107Q34342494-11710AFF-B5E4-463D-9357-591F192B0815
P2860
Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Identification of amino acid r ...... sulfate proteoglycan binding.
@en
Identification of amino acid r ...... sulfate proteoglycan binding.
@nl
type
label
Identification of amino acid r ...... sulfate proteoglycan binding.
@en
Identification of amino acid r ...... sulfate proteoglycan binding.
@nl
prefLabel
Identification of amino acid r ...... sulfate proteoglycan binding.
@en
Identification of amino acid r ...... sulfate proteoglycan binding.
@nl
P2093
P2860
P1433
P1476
Identification of amino acid r ...... sulfate proteoglycan binding.
@en
P2093
Kenneth H Warrington
Nicholas Muzyczka
Sergei Zolotukhin
Shaun R Opie
P2860
P304
P356
10.1128/JVI.77.12.6995-7006.2003
P407
P577
2003-06-01T00:00:00Z